4.5 Article

Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk

Samuel K. Powell et al.

Summary: Rapid and efficient induction of dopaminergic neurons can be achieved through transient overexpression of lineage-promoting transcription factors combined with stringent selection. These induced dopaminergic neurons provide a critical tool for modeling midbrain dopaminergic neuron development and dysfunction in psychiatric disease.

MOLECULAR PSYCHIATRY (2023)

Article Psychology, Developmental

Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder

Majd Al-Soleiti et al.

Summary: There is growing interest in investigating the use of cannabis for behavioral symptoms in individuals with ASD, but caution is advised until large-scale, replicated randomized controlled trials have demonstrated its efficacy, safety, and tolerability.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2022)

Article Neurosciences

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis

Eef L. Theunissen et al.

Summary: The study aimed to assess the psychotomimetic effects of a moderate dose of JWH-018, revealing that it induces pronounced psychotomimetic symptoms in healthy participants with no history of mental illness, confirming the serious risk SCs pose for public health.

PSYCHOPHARMACOLOGY (2022)

Review Neurosciences

Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence

Riccardo Bortoletto et al.

Summary: Palmitoylethanolamide (PEA) has neuroprotective, anti-inflammatory, and analgesic properties, and has shown to reduce seizure frequency and severity in animal models, potentially preventing neural damage.

BRAIN SCIENCES (2022)

Review Environmental Sciences

The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System

Marco Colizzi et al.

Summary: Evidence suggests that autism and psychosis share similar physiological mechanisms, with the endocannabinoid system playing a potential role in regulating neural circuits during neurodevelopment. However, more research is needed to differentiate between the two conditions and identify common markers for diagnosis and treatment.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Review Substance Abuse

Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis

Sarah Kanana Kiburi et al.

Summary: Adolescent cannabis use is associated with an increased risk for psychosis later in life, with factors such as age of onset, frequency of use, childhood trauma, concurrent substance use, and genetic factors moderating this relationship. Further research is needed to fully understand the interaction between these factors and psychosis risk.

SUBSTANCE ABUSE (2021)

Review Neurosciences

Prevalence of Individuals at Clinical High-Risk of Psychosis in the General Population and Clinical Samples: Systematic Review and Meta-Analysis

Gonzalo Salazar de Pablo et al.

Summary: The prevalence of the CHR-P state is low in the general population and ten times higher in clinical samples. The prevalence of CHR-P may increase with a higher proportion of females in the general population and with a younger population in clinical samples. The CHR-P state may be unrecognized in routine clinical practice. These findings can refine detection and preventive strategies.

BRAIN SCIENCES (2021)

Review Nutrition & Dietetics

Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence

Marco Colizzi et al.

Summary: Studies suggest altered levels of PEA and other endocannabinoids in ASD, and PEA supplementation may reduce autism severity by improving language and social behaviors. Potential neurobiological mechanisms include modulation of immune response, neuroinflammation, neurotrophy, apoptosis, neurogenesis, neuroplasticity, neurodegeneration, mitochondrial function, and microbiota activity.

NUTRIENTS (2021)

Article Psychiatry

Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank

Michael Wainberg et al.

Summary: The study reveals a strong association between cannabis use and psychotic experiences, particularly persecutory delusions. Individuals genetically predisposed to schizophrenia are more susceptible to auditory and visual hallucinations, as well as overall psychotic experiences, as a result of cannabis use.

TRANSLATIONAL PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

The importance of a developmental perspective in Psychiatry: what do recent genetic-epidemiological findings show?

Anita Thapar et al.

MOLECULAR PSYCHIATRY (2020)

Article Environmental Sciences

Subacute cannabidiol alters genome-wideDNAmethylation in adult mouse hippocampus

Nicole M. Wanner et al.

ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2020)

Review Psychology, Multidisciplinary

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

Marco Colizzi et al.

FRONTIERS IN PSYCHOLOGY (2020)

Article Neurosciences

Neurodevelopmental disorders-the history and future of a diagnostic concept

Deborah J. Morris-Rosendahl et al.

DIALOGUES IN CLINICAL NEUROSCIENCE (2020)

Review Psychiatry

The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years

Shera Hosseini et al.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2019)

Article Multidisciplinary Sciences

Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy

Lihi Bar-Lev Schleider et al.

SCIENTIFIC REPORTS (2019)

Article Pharmacology & Pharmacy

Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities

Dana Barchel et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Psychiatry

THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders

Boris Guennewig et al.

TRANSLATIONAL PSYCHIATRY (2018)

Article Biochemistry & Molecular Biology

β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling

Garret R. Anderson et al.

Review Clinical Neurology

Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date

Musa Basser Sami et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)

Editorial Material Multidisciplinary Sciences

Perspective: Be clear about the real risks

Matthew Hill

NATURE (2015)

Review Substance Abuse

Adolescent Initiation of Cannabis Use and Early-Onset Psychosis

Kara S. Bagot et al.

SUBSTANCE ABUSE (2015)

Article Pharmacology & Pharmacy

Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders

E. S. Onaivi et al.

Current Neuropharmacology (2011)